Pediatrics
Latest News
Teenagers get in the queue for COVID-19 vaccines
Several drug companies are planning to begin trials in children and adolescents.
News from the FDA/CDC
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Completed safety clinical trial shows occurrence of heart-related events and cancer in RA patients taking the Janus kinase inhibitor is higher...
Feature
Tofacitinib for RA misses the mark in safety study
Pfizer announced primary outcome results for major adverse cardiovascular events and cancers in postmarketing ORAL Surveillance study.
Latest News
New dietary guidelines omit recommended cuts to sugar, alcohol intake
The guidelines omit a recommendation from the advisory committee’s ...
From the Journals
Infant’s COVID-19–related myocardial injury reversed
Children hospitalized for COVID-19 should be tested for heart failure based on a case report of an infant with COVID-19 and reversible myocardial...
From the Journals
Obesity, hypoxia predict severity in children with COVID-19
Race, ethnicity, and socioeconomic status were not significant predictors of serious illness.
Conference Coverage
Metformin improves most outcomes for T2D during pregnancy
But the drug was associated with an increased risk of small-for-gestational-age babies.
Feature
COVID-19 cases in children continue to set records
More than 1.18 million U.S. children have been infected by the coronavirus since the beginning of the pandemic.
From the Journals
Experts disagree with USPSTF’s take on pediatric blood pressure screening
Commentary
Should our patients really go home for the holidays?
Risks to warn patients of include high-risk status, risk of SARS-CoV-2 transmission and how to mitigate it, and mode of transportation.
Feature
United States adds nearly 74,000 more children with COVID-19
New weekly high in pediatric cases seen for the second consecutive week.